Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients
- 29 January 1999
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 57 (2) , 140-144
- https://doi.org/10.1002/(sici)1096-9071(199902)57:2<140::aid-jmv9>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981–1996International Journal of Cancer, 1998
- Seroprevalence of HHV-8 Antibodies in HIV-Positive Homosexual Men Without Kaposi’s Sarcoma and Their Clinical Follow-UpAmerican Journal of Clinical Pathology, 1998
- Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposiʼs sarcomaAIDS, 1998
- Sexual Transmission and the Natural History of Human Herpesvirus 8 InfectionNew England Journal of Medicine, 1998
- Reduction of Kaposiʼs sarcoma lesions following treatment of AIDS with ritonovirAIDS, 1997
- Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitorThe Lancet, 1997
- Human Herpesvirus 8 Is Present in the Lymphoid System of Healthy Persons and Can Reactivate in the Course of AIDSThe Journal of Infectious Diseases, 1996
- HIV protease inhibitorsAIDS, 1996
- Herpes-Like Sequences in HIV-Infected and Uninfected Kaposi's Sarcoma PatientsScience, 1995
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994